These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15456919)

  • 1. Human carcinogenic risk evaluation, Part V: The national toxicology program vision for assessing the human carcinogenic hazard of chemicals.
    Bucher JR; Portier C
    Toxicol Sci; 2004 Dec; 82(2):363-6. PubMed ID: 15456919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speculations on the rodent carcinogenicity of 30 chemicals currently under evaluation in rat and mouse bioassays organised by the U.S. National Toxicology Program.
    Bootman J
    Environ Mol Mutagen; 1996; 27(3):237-43. PubMed ID: 8625960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans?
    Monro A
    Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of chemicals for testing in the rodent cancer bioassay.
    Takihi N; Rosenkranz HS; Klopman G
    Qual Assur; 1993 Sep; 2(3):232-43. PubMed ID: 8137083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing computational toxicology models with phytochemicals.
    Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
    Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.
    Cohen SM
    Exp Toxicol Pathol; 2010 Sep; 62(5):497-502. PubMed ID: 19616417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach to risk assessment requires the use of biological information: an analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors.
    Goodman JI
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):51-9. PubMed ID: 8159815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
    Thomas RS; Pluta L; Yang L; Halsey TA
    Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.
    Waters M; Jackson M
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of carcinogenic and noncarcinogenic chemicals.
    Johannsen FR
    Crit Rev Toxicol; 1990; 20(5):341-67. PubMed ID: 2202326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
    Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of rodent carcinogens by an expert system.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1990; 340B():23-48. PubMed ID: 2203007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.